Literature DB >> 28983902

Intractable seizures after a lengthy remission in childhood-onset epilepsy.

Peter R Camfield1, Carol S Camfield1.   

Abstract

OBJECTIVES: To establish the risk of subsequent intractable epilepsy after ≥2, ≥5, and ≥10 years of remission in childhood-onset epilepsy.
METHODS: From the Nova Scotia childhood-onset epilepsy population-based cohort patients with all types of epilepsy were selected with ≥20 years follow-up from seizure onset (incidence cases). Children with childhood absence epilepsy were excluded. The rate of subsequent intractable epilepsy was then studied for patients with ≥5 years remission on or off AED treatment and compared with the rate for those with ≥2 and ≥10 years of remission.
RESULTS: Three hundred eighty-eight eligible patients had ≥20 years follow-up (average 27.7 ± (standard deviation) 4 years) until they were an average of 34 ± 6.5 years of age. Overall, 297 (77%) had a period of ≥5 years of seizure freedom (average 21.2 ± 8 years), with 90% of these remissions continuing to the end of follow-up. Seizures recurred in 31 (10%) and were intractable in 7 (2%). For the 332 with a remission of ≥2 years seizure-free, 6.9% subsequently developed intractable epilepsy (p = 0.001). For the 260 with ≥10 years remission, 0.78% subsequently developed intractable epilepsy (p = 0.25 compared with ≥5 years remission). SIGNIFICANCE: Even after ≥5 or ≥10 years of seizure freedom, childhood-onset epilepsy may reappear and be intractable. The risk is fortunately small, but for most patients it is not possible to guarantee a permanent remission. Wiley Periodicals, Inc.
© 2017 International League Against Epilepsy.

Entities:  

Keywords:  Childhood; Epidemiology; Epilepsy; Intractability; Remission

Mesh:

Year:  2017        PMID: 28983902     DOI: 10.1111/epi.13916

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

1.  Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics.

Authors:  Arife Çimen Atalar; Ebru Nur Vanlı-Yavuz; Ebru Yılmaz; Nerses Bebek; Betül Baykan
Journal:  J Neurol       Date:  2019-12-02       Impact factor: 4.849

2.  Adolescent-onset absence epilepsy years after resolution of childhood epilepsy with myoclonic-atonic seizures.

Authors:  Sarah H Berth; Eric H Kossoff
Journal:  Epilepsy Behav Rep       Date:  2019-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.